RICHMOND AIDS CONSORTIUM 'CPCRA'
RICHMOND AIDS CONSORTIUM 'CPCRA'
批准号:
6729928
负责人:
DANIEL E NIXON
金额:
$94.89万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-01 至 2007-03-31
关键词:
AIDSAIDS /HIV diagnosisAIDS therapyantiAIDS agentchemopreventionclinical researchclinical trialscommunity health servicescooperative studydrug screening /evaluationhuman subjecthuman therapy evaluationlongitudinal human studyopportunistic infectionspatient oriented researchprognosistherapy compliance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from application's abstract): The long-term objective of
the Richmond AIDS Consortium (RAC) is to acquire knowledge regarding the
clinical management of HIV infection through the conduct of therapeutic trials
in populations who are traditionally underrepresented in clinical research and
often without access to state-of-the-art health care. This will be achieved
throughout the life of this proposal by adhering to the following design
points: (1) each individual will have a primary care physician, versed in the
management of HIV, and responsible for the individual's comprehensive medical
care; (2) research nurses will follow patients in real time during the
patients' office visits; and (3) social work and pharmacy services will be
available for all patients. The infrastructure for this design consists of a
network of primary care providers at Virginia Commonwealth University/Medical
College of Virginia Hospital (VCH/MCVH) and its associated Veterans Hospital,
seven physicians in the Richmond metropolitan community, and the addition of a
new site associated with Eastern Virginia Medical School in Norfolk. The
total number of patients immediately available is 2,828 with another 4,000
present in the catchment area. One central IRB, one central laboratory, and
one central pharmacy are all in place and functioning. A Community Advisory
Board (CAB) is functioning and contributes to the Research Agenda through
patient recruitment and advice on concepts and protocols. Investigators will
contribute to the Research Agenda through enrolling patients, and
participating in concept and protocol development. A QA plan is in place,
methods for data collection and review, adverse event reporting, regulatory
affairs and sound fiscal management and accountability. RAC is eager to start
the IL-2, PIP and FIRST protocols and expects to either enroll or be following
200 patients at the unit at any given time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/ HIV-1 INFECTION
-
批准号:7375123
-
项目类别:
-
资助金额:$1.58万
-
财政年份:2005
-
负责人:DANIEL E NIXON
-
依托单位:
PHASE III STUDY OF SUBCUTANEOUS RECOMBINANT IL-2 IN PATIENTS W/ HIV-1 INFECTION
-
批准号:7201479
-
项目类别:
-
资助金额:$5.68万
-
财政年份:2004
-
负责人:DANIEL E NIXON
-
依托单位:
RICHMOND AIDS CONSORTIUM 'CPCRA'
-
批准号:7049990
-
项目类别:
-
资助金额:$94.98万
-
财政年份:2000
-
负责人:DANIEL E NIXON
-
依托单位:
RICHMOND AIDS CONSORTIUM 'CPCRA'
-
批准号:7193674
-
项目类别:
-
资助金额:$63.09万
-
财政年份:2000
-
负责人:DANIEL E NIXON
-
依托单位:
HERPESVIRUS GENOMIC CLEAVAGE
-
批准号:6372572
-
项目类别:
-
资助金额:$12.47万
-
财政年份:1997
-
负责人:DANIEL E NIXON
-
依托单位:
HERPESVIRUS GENOMIC CLEAVAGE
-
批准号:2886042
-
项目类别:
-
资助金额:$9.03万
-
财政年份:1997
-
负责人:DANIEL E NIXON
-
依托单位:
HERPESVIRUS GENOMIC CLEAVAGE
-
批准号:2671440
-
项目类别:
-
资助金额:$7.95万
-
财政年份:1997
-
负责人:DANIEL E NIXON
-
依托单位:
HERPESVIRUS GENOMIC CLEAVAGE
-
批准号:2404046
-
项目类别:
-
资助金额:$7.95万
-
财政年份:1997
-
负责人:DANIEL E NIXON
-
依托单位:
HERPESVIRUS GENOMIC CLEAVAGE
-
批准号:6169113
-
项目类别:
-
资助金额:$12.47万
-
财政年份:1997
-
负责人:DANIEL E NIXON
-
依托单位: